Ai-Min Hui

机构：Takeda (United States), Millennium Engineering and Integration (United States)

发表论文 19 篇 · 总被引 3750 次 · h-index 16

代表论文

• Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma (2016 · New England Journal of Medicine · 被引 1059)
• Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain (2006 · Cancer Cell · 被引 908)
• Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy (1999 · Hepatology · 被引 319)
• Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study (2014 · The Lancet Oncology · 被引 266)
• The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas (1997 · International Journal of Cancer · 被引 253)
• Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients (2014 · Blood · 被引 203)